FindTrial
Sign In

Registry to detect all patients who underwent stereotactic and/or neurosurgical treatment for their brainmetastasis at the Universityhospital Cologne

Registry to detect all patients who underwent stereotactic and/or neurosurgical treatment for their brainmetastasis at the Universityhospital Cologne

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
DRKS
Registry ID
DRKS00030830
Enrollment
1000
Registered
2023-01-04
Start date
2023-02-01
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

C79.3

Interventions

Group 1: All patients, who underwent stereotactic and/or neurosurgical treatment for their brainmetastasis at the Universityhospital Cologne including the adjuvant radiooncological treatment and follo

Sponsors

Zentrum für Neurochirurgie der Uniklinik Köln
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 100 Years

Inclusion criteria

Inclusion criteria: Registry to detect all patients who underwent stereotactic and/or neurosurgical treatment for their brainmetastasis from a (known) systemic primary at the Universityhospital Cologne, who are at least 18 years old at the time of their treatment.

Exclusion criteria

Exclusion criteria: All patients, who don't meet the inclusion criteria

Design outcomes

Primary

MeasureTime frame
Registry, no primary endpoint planned—

Countries

Germany

Contacts

Public ContactStephanie Jünger

Zentrum für Neurochirurgie Universitätsklinikum Köln

stephanie.juenger@uk-koeln.de022147882733

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026